The Valley Desk

Clinical trial reportOphthalmology. RetinaPublished

TALON Phase IIIb Study: 32-Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age-Related Macular Degeneration

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Thomas Jefferson University, Wills Eye Hospital. Affiliation source

Publication record

Type
Clinical trial report
Venue
Ophthalmology. Retina
Published
Subject terms
Fundus Oculi; Macula Lutea; Humans; Receptors, Vascular Endothelial Growth Factor; Angiogenesis Inhibitors; Recombinant Fusion Proteins; Tomography, Optical Coherence; Fluorescein Angiography; Treatment Outcome; Follow-Up Studies; Double-Blind Method; Visual Acuity
PubMed ID
40466770
Added to directory
Source checked

Report a correction or request removal